The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Ishares Msci South Africa Index Fund

NYSE: EZA
Last

(U.S.) $71.83

Today's change-0.52 -0.72%
Updated January 19 8:00 PM -5GMT. Delayed by at least 15 minutes.
 

Ishares Msci South Africa Index Fund

NYSE: EZA
Last

(U.S.) $71.83

Today's change-0.52 -0.72%
Updated January 19 8:00 PM -5GMT. Delayed by at least 15 minutes.

Ishares Msci South Africa Index Fund down (U.S.)$0.52

Ishares Msci South Africa Index Fund closed lower Friday, dropping (U.S.)$0.52 or 0.72% to (U.S.)$71.83. Over the last five days, shares have gained 3.29% and outperformed the S&P 500 index over the last 52 weeks with a 31.80% increase in price.

Key company metrics

  • Open(U.S.) $71.69
  • Previous close(U.S.) $72.35
  • High(U.S.) $72.02
  • Low(U.S.) $71.06
  • Bid / Ask-- / --
  • YTD % change+2.63%
  • Volume561,901
  • Average volume (10-day)435,368
  • Average volume (1-month)526,593
  • Average volume (3-month)474,729
  • 52-week range(U.S.) $53.75 to (U.S.) $72.52
  • Beta1.01
  • Trailing P/E16.57×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.08
  • Dividend yield1.51%
  • Trailing EPS(U.S.) $4.33
Updated January 19 8:00 PM -5GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+341.32%

Based on its net profit margin of 341.32%, Ishares Msci South Africa Index Fund is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.42%Sector:FinancialsIndustry:Investment Trusts

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q4/2014Q2/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedFeb 28, 201502/28/2015Aug 31, 201408/31/2014Feb 28, 201402/28/2014Aug 31, 201308/31/2013
Revenue5887
Total other revenue--------
Total revenue5887
Gross profit4675
Total cost of revenue1222
Total operating expense1222
Selling / general / administrative--------
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income4675
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-237038-45
Income after tax-237038-45
Income tax, total--000
Net income-237038-45
Total adjustments to net income--------
Net income before extra. items-237038-45
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-237038-45
Inc. avail. to common incl. extra. items-237038-45
Diluted net income-237038-45
Dilution adjustment--------
Diluted weighted average shares79711
Diluted EPS excluding extraordinary itemsvalue per share-3.187.525.26-4.19
Dividends per sharevalue per share0.800.620.920.65
Diluted normalized EPSvalue per share-3.187.525.26-4.19